STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Apr. 26, 2020

Share-based Payment Arrangement [Abstract]

Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable (in thousands) as of April 26, 2020 is:

	Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Stock Options Outstanding at October 27, 2019	25,994	$	26.49
Granted	1,209	45.86
Exercised	4,927	15.40
Forfeited	124	36.41
Stock Options Outstanding at April 26, 2020	22,152	29.96		5.6	$	369,036
Stock Options Exercisable at April 26, 2020	15,141	$	25.63	4.3	$	317,637

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised (in thousands) during the thirteen and twenty-six weeks ended April 26, 2020, and April 28, 2019, are:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	April 26, 2020		April 28, 2019		April 26, 2020		April 28, 2019
Weighted-average Grant Date Fair Value	$	7.92	$	8.21	$	7.71	$	9.24
Intrinsic Value of Exercised Options	55,948		75,545		153,894		107,786

Schedule of weighted-average assumptions used to calculate fair value of each option award

The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	April 26, 2020		April 28, 2019		April 26, 2020		April 28, 2019
Risk-free Interest Rate	1.5	%	2.6	%	1.7	%	2.8	%
Dividend Yield	2.0	%	2.0	%	2.0	%	1.9	%
Stock Price Volatility	19.0	%	19.0	%	19.0	%	19.0	%
Expected Option Life	8 years		8 years		8 years		8 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the restricted stock units (in thousands) as of April 26, 2020 is:

	Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Restricted Stock Units Outstanding at October 27, 2019	—	$	—
Granted	203	45.86
Vested	7	45.54
Restricted Stock Units Outstanding at April 26, 2020	196	$	45.87	2.1	$	9,114

A reconciliation of the restricted shares (in thousands) as of April 26, 2020 is:

	Shares	Weighted- Average Grant Date Fair Value
Restricted Shares Outstanding at October 27, 2019	51	$	42.23
Granted	41	47.29
Vested	47	42.08
Restricted Shares Outstanding at April 26, 2020	45	$	47.03

Schedule of the weighted-average grant date fair value and fair value of nonvested shares granted

The weighted-average grant date fair value of restricted stock units granted and the total fair value (in thousands) of restricted stock units granted during the thirteen and twenty-six weeks ended April 26, 2020, and April 28, 2019, are:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	April 26, 2020		April 28, 2019		April 26, 2020		April 28, 2019
Weighted-average Grant Date Fair Value	$	47.43	$	—	$	45.86	$	—
Fair Value of Restricted Stock Units Granted	1,625		—		9,320		—

The weighted-average grant date fair value of restricted shares granted, the total fair value (in thousands) of restricted shares granted, and the fair value (in thousands) of shares that have vested during the twenty-six weeks ended April 26, 2020, and April 28, 2019, are:

	Twenty-Six Weeks Ended
	April 26, 2020		April 28, 2019
Weighted-average Grant Date Fair Value	$	47.29	$	42.23
Fair Value of Restricted Shares Granted	1,973		2,134
Fair Value of Shares Vested	1,974		1,760